Evidence map›Paper›PMID 20962129›Full record

ArticleJournal of the American Medical Informatics Association : JAMIA

Drug safety surveillance using de-identified EMR and claims data: issues and challenges.

Prakash M Nadkarni

Abstract read
In one paragraph

Article in Journal of the American Medical Informatics Association : JAMIA. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Adverse drug event rates in pediatric pulmonary hypertension: a comparison of real-world data sources.Journal of the American Medical Informatics Association : JAMIA · 2020
    Article
  12. A study of deep learning approaches for medication and adverse drug event extraction from clinical text.Journal of the American Medical Informatics Association : JAMIA · 2020
    Article
  13. Extracting Adverse Drug Event Information with Minimal Engineering.Proceedings of the conference. Association for Computational Linguistics. North American Chapter. Meeting · 2019
    Article
  14. Article
  15. Article
  16. Development of an algorithm to link electronic health record prescriptions with pharmacy dispense claims.Journal of the American Medical Informatics Association : JAMIA · 2018
    Article
  17. Review
  18. Article
  19. Article
  20. Computational Drug Repositioning Using Continuous Self-Controlled Case Series.KDD : proceedings. International Conference on Knowledge Discovery & Data Mining · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Prakash M NadkarniCenter for Medical Informatics, Yale University School of Medicine, New Haven, CT 06511, USA. prakash.nadkarni@yale.edu

Funding

ROBUST QUERY OF HETEROGENEOUS CLINICAL DATABASESR01LM006843 · NLM · YALE UNIVERSITY · PI NADKARNI, PRAKASH M. · 2000 to 2002
$878k
NLM NIH HHS R01 LM006843
6 · The paper itself

Abstract

The author discusses the challenges of pharmacovigilance using electronic medical record and claims data. Use of ICD-9 encoded data has low sensitivity for detection of adverse drug events (ADEs), because it requires that an ADE escalate to major-complaint level before it can be identified, and because clinical symptomatology is relatively under-represented in ICD-9. A more appropriate vocabulary for ADE identification, SNOMED CT, awaits wider deployment. The narrative-text record of progress notes can potentially be used for more sensitive ADE detection. More effective surveillance will require the ability to grade ADEs by severity. Finally, access to online drug information that includes both a reliable hierarchy of drug families as well as structured information on existing ADEs can improve the focus and predictive ability of surveillance efforts.

Indexed as

Adverse Drug Reaction Reporting SystemsDose-Response Relationship, DrugElectronic Health RecordsHumansInsurance Claim ReviewProduct Surveillance, PostmarketingSensitivity and SpecificityUnited StatesVocabulary, Controlled

Identifiers

PMID20962129
PMCPMC3000764

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.